NCT06728098

Safety and Tolerability Evaluation of Akkermansia Muciniphila

Safety and Tolerability Evaluation of Heat-Inactivated Akkermansia Muciniphila Akk11: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 108 (estimated)
• Sponsor: Wecare Probiotics Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

This is a randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of Akkermansia muciniphila Akk11 in healthy adult.

Conditions

• Healthy

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Probiotic	The experimental phase of this study had last 30 days and each patient will make 3 visits (d1,d15,d30).
DIETARY_SUPPLEMENT	Maltodextrin	The experimental phase of this study had last 30 days and each patient will make 3 visits (d1,d15,d30).

Timeline

• Start date: 2025-11-25
• Primary completion: 2025-12-25
• Completion: 2026-03-25
• First posted: 2024-12-11
• Last updated: 2025-07-29

Locations

1 site across 1 country: Indonesia